Diabetic Macular Edema

Showing NaN - NaN of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetic Macular Edema Trial in Austin (Experimental: Group 1, Experimental: Group 2, Experimental: Group 3)

Recruiting
  • Diabetic Macular Edema
  • Experimental: Group 1
  • +3 more
  • Austin, Texas
    Rezolute Investigative Site, Austin, TX
Jan 31, 2023

Diabetic Macular Edema Trial in Puerto Rico, United States (Faricimab)

Recruiting
  • Diabetic Macular Edema
  • Mesa, Arizona
  • +43 more
Jan 31, 2023

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Austin, Texas
    Retina Consultants of Austin
Jan 16, 2023

Diabetic Macular Edema Trial in Worldwide (Faricimab)

Completed
  • Diabetic Macular Edema
  • Santa Barbara, California
  • +26 more
Dec 23, 2022

Diabetic Macular Edema Trial in Puerto Rico, United States (CU06-1004)

Recruiting
  • Diabetic Macular Edema
  • Baltimore, Maryland
  • +9 more
Dec 13, 2022

Diabetic Macular Edema Trial in United States (intravitreous aflibercept, Bevacizumab + Deferred Aflibercept Group)

Completed
  • Diabetic Macular Edema
  • intravitreous aflibercept
  • Bevacizumab + Deferred Aflibercept Group
  • Campbell, California
  • +53 more
Nov 28, 2022

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Enrolling by invitation
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • ADVM-022
  • Beverly Hills, California
  • +6 more
Nov 4, 2022

Wet Age-related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema Trial in United States (KSI-301)

Terminated
  • Wet Age-related Macular Degeneration
  • +2 more
  • Phoenix, Arizona
  • +10 more
Nov 1, 2022

Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-149 dose level 1, THR-149 dose level 2, THR-149

Recruiting
  • Diabetes Mellitus
  • +2 more
  • THR-149 dose level 1
  • +6 more
  • Beverly Hills, California
  • +60 more
Aug 9, 2022

Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in Worldwide (THR-687 dose level 1, THR-687 dose level 2, THR-687

Terminated
  • Diabetes Mellitus
  • +2 more
  • THR-687 dose level 1
  • +3 more
  • Huntington Beach, California
  • +24 more
Jul 19, 2022

Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • Bakersfield, California
  • +45 more
Jun 2, 2022

Diabetic Macular Edema Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +87 more
Jun 2, 2022

Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +194 more
Apr 1, 2022

Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • Mesa, Arizona
  • +184 more
Apr 1, 2022

Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of

Active, not recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • 6E11 vg/eye of ADVM-022
  • +2 more
  • Phoenix, Arizona
  • +13 more
Jan 10, 2022

Diabetic Macular Edema Trial in United States (IVT aflibercept, Sham SC, SC CLS-TA)

Completed
  • Diabetic Macular Edema
  • IVT aflibercept
  • +2 more
  • Phoenix, Arizona
  • +28 more
Apr 22, 2021

Diabetic Macular Edema Trial in United States (KVD001 Injection, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • KVD001 Injection
  • Sham Procedure
  • Phoenix, Arizona
  • +34 more
Jan 5, 2021

Diabetic Macular Edema Trial in United States (Faricimab, Ranibizumab)

Completed
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +59 more
Aug 31, 2020

Diabetic Retinopathy, Diabetic Macular Edema Trial in Canada, United States (Pemafibrate, Placebo)

Terminated
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +70 more
Aug 27, 2020

Diabetic Macular Edema Trial in United States (2.0 mg intravitreal aflibercept, 1.25 mg intravitreal bevacizumab, 0.3 mg

Completed
  • Diabetic Macular Edema
  • 2.0 mg intravitreal aflibercept
  • +2 more
  • Tucson, Arizona
  • +89 more
Jul 22, 2020

Evaluation of Vitrectomy for Diabetic Macular Edema

Completed
  • Diabetic Retinopathy
  • Diabetic Macular Edema
    • Irvine, California
    • +47 more
    Sep 20, 2019

    Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in United States (THR-149 dose level 1, THR-149 dose level 2,

    Completed
    • Diabetes Mellitus
    • +2 more
    • THR-149 dose level 1
    • +2 more
    • Phoenix, Arizona
    • +6 more
    Jun 12, 2019

    Diabetes, Diabetic Macular Edema Trial in United States (ASP8232, ranibizumab, Placebo)

    Completed
    • Diabetes Mellitus
    • Diabetic Macular Edema
    • Phoenix, Arizona
    • +20 more
    Mar 4, 2019

    Diabetic Macular Edema Trial in United States (Luminate 1.0mg, Luminate 2.0mg, Luminate 3.0mg)

    Completed
    • Diabetic Macular Edema
    • Luminate 1.0mg
    • +4 more
    • Phoenix, Arizona
    • +16 more
    Dec 5, 2018